ARTICLE | Company News
Alkermes Inc., Bioject deal
October 29, 2001 8:00 AM UTC
The companies will develop up to three undisclosed compounds for ALKS using BJCT’s Iject and potentially other BJCT needle-free delivery systems. ALKS will pay BJCT monthly fees and milestones. ...